If you liked this article you might like

ProQR Cystic Fibrosis Drug Passes First, Early Efficacy Test
5 Stocks Under $10 Set to Soar
Vertex to Test New Cystic Fibrosis Drugs, Seeking Broader, More Effective Treatments
Biotech Stock Mailbag: ProQR, Vertex Pharma, Tekmira, Agios